175 related articles for article (PubMed ID: 20636866)
1. Evaluation of the effect of topical agents on radiation-induced skin disease by reflectance spectrophotometry.
Rizza L; D'Agostino A; Girlando A; Puglia C
J Pharm Pharmacol; 2010 Jun; 62(6):779-85. PubMed ID: 20636866
[TBL] [Abstract][Full Text] [Related]
2. Does aqueous or sucralfate cream affect the severity of erythematous radiation skin reactions? A randomised controlled trial.
Wells M; Macmillan M; Raab G; MacBride S; Bell N; MacKinnon K; MacDougall H; Samuel L; Munro A
Radiother Oncol; 2004 Nov; 73(2):153-62. PubMed ID: 15542162
[TBL] [Abstract][Full Text] [Related]
3. Thêta-Cream versus Bepanthol lotion in breast cancer patients under radiotherapy. A new prophylactic agent in skin care?
Röper B; Kaisig D; Auer F; Mergen E; Molls M
Strahlenther Onkol; 2004 May; 180(5):315-22. PubMed ID: 15127162
[TBL] [Abstract][Full Text] [Related]
4. The effect of vitamin E on acute skin reaction caused by radiotherapy.
Dirier A; Akmansu M; Bora H; Gurer M
Clin Exp Dermatol; 2007 Sep; 32(5):571-3. PubMed ID: 17535282
[TBL] [Abstract][Full Text] [Related]
5. [Prevention and therapy of radiodermatitis in postoperative radiotherapy following mastectomy].
Kastratović M; Rödl W
Fortschr Med; 1971 Aug; 89(22):889-90. PubMed ID: 5154177
[No Abstract] [Full Text] [Related]
6. Topical use of phytotherapic cream (Capilen® cream) to prevent radiodermatitis in breast cancer: a prospective historically controlled clinical study.
Stefanelli A; Forte L; Medoro S; Sgualdo A; Lombardo D; Zini G; Maronta D; Rainieri E; Pascale G; Bagnolatti P; Colella M; Princivalle S; Fiorica F
G Ital Dermatol Venereol; 2014 Feb; 149(1):107-13. PubMed ID: 24566571
[TBL] [Abstract][Full Text] [Related]
7. Effects of oral epigallocatechin gallate supplementation on the minimal erythema dose and UV-induced skin damage.
Jeon HY; Kim JK; Kim WG; Lee SJ
Skin Pharmacol Physiol; 2009; 22(3):137-41. PubMed ID: 19212149
[TBL] [Abstract][Full Text] [Related]
8. Double-Blind, Placebo-Controlled Pilot Study of Processed Ultra Emu Oil Versus Placebo in the Prevention of Radiation Dermatitis.
Rollmann DC; Novotny PJ; Petersen IA; Garces YI; Bauer HJ; Yan ES; Wahner-Roedler D; Vincent A; Sloan JA; Issa Laack NN
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(3):650-8. PubMed ID: 25936812
[TBL] [Abstract][Full Text] [Related]
9. Radioprotective effect of moderate wine consumption in patients with breast carcinoma.
Morganti AG; Digesù C; Panunzi S; De Gaetano A; Macchia G; Deodato F; Cece MG; Cirocco M; Di Castelnuovo A; Iacoviello L; Valentini V; Cellini N; de Gaetano G
Int J Radiat Oncol Biol Phys; 2009 Aug; 74(5):1501-5. PubMed ID: 19395196
[TBL] [Abstract][Full Text] [Related]
10. [The immediate and late results of protecting the patient's normal tissues by using the gas hypoxic mixture GHM-10 in the radiation therapy of breast cancer].
Strelkov RB; Mardynskiĭ IuS; Zakoshchikov KF; Firsova PP
Vopr Onkol; 1985; 31(12):35-9. PubMed ID: 4082505
[TBL] [Abstract][Full Text] [Related]
11. Measurement of breast skin viscoelasticity and a pilot study on the potential radioprotective effect of a zinc-based cream.
Gorodetsky R; Andriessen A; Polyansky I; Vexler A
J Wound Care; 1999 Nov; 8(10):514-8. PubMed ID: 10827657
[TBL] [Abstract][Full Text] [Related]
12. Thrombin generation as a predictor of radiotherapy induced skin erythema.
Lincz LF; Gupta SA; Wratten CR; Kilmurray J; Nash S; Seldon M; O'Brien PC; Bell KJ; Denham JW
Radiother Oncol; 2009 Jan; 90(1):136-40. PubMed ID: 19012979
[TBL] [Abstract][Full Text] [Related]
13. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis.
Pignol JP; Olivotto I; Rakovitch E; Gardner S; Sixel K; Beckham W; Vu TT; Truong P; Ackerman I; Paszat L
J Clin Oncol; 2008 May; 26(13):2085-92. PubMed ID: 18285602
[TBL] [Abstract][Full Text] [Related]
14. Topical Biafine and Lipiderm for the prevention of radiation dermatitis: a randomized prospective trial.
Fenig E; Brenner B; Katz A; Sulkes J; Lapidot M; Schachter J; Malik H; Sulkes A; Gutman H
Oncol Rep; 2001; 8(2):305-9. PubMed ID: 11182045
[TBL] [Abstract][Full Text] [Related]
15. Endogenous phospholipid metabolite containing topical product inhibits ultraviolet light-induced inflammation and DNA damage in human skin.
Kemeny L; Koreck A; Kis K; Kenderessy-Szabo A; Bodai L; Cimpean A; Paunescu V; Raica M; Ghyczy M
Skin Pharmacol Physiol; 2007; 20(3):155-61. PubMed ID: 17230055
[TBL] [Abstract][Full Text] [Related]
16. [Radiation induced skin reactions].
Clavère P; Bonnafoux-Clavère A; Bonnetblanc JM
Ann Dermatol Venereol; 2008 Jan; Spec No 1():1-4. PubMed ID: 18342110
[TBL] [Abstract][Full Text] [Related]
17. Topical hyaluronic acid vs. standard of care for the prevention of radiation dermatitis after adjuvant radiotherapy for breast cancer: single-blind randomized phase III clinical trial.
Pinnix C; Perkins GH; Strom EA; Tereffe W; Woodward W; Oh JL; Arriaga L; Munsell MF; Kelly P; Hoffman KE; Smith BD; Buchholz TA; Yu TK
Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):1089-94. PubMed ID: 22172912
[TBL] [Abstract][Full Text] [Related]
18. A phase I study of topical Tempol for the prevention of alopecia induced by whole brain radiotherapy.
Metz JM; Smith D; Mick R; Lustig R; Mitchell J; Cherakuri M; Glatstein E; Hahn SM
Clin Cancer Res; 2004 Oct; 10(19):6411-7. PubMed ID: 15475427
[TBL] [Abstract][Full Text] [Related]
19. Topical use of a silymarin-based preparation to prevent radiodermatitis : results of a prospective study in breast cancer patients.
Becker-Schiebe M; Mengs U; Schaefer M; Bulitta M; Hoffmann W
Strahlenther Onkol; 2011 Aug; 187(8):485-91. PubMed ID: 21786113
[TBL] [Abstract][Full Text] [Related]
20. Phase III randomized trial of Calendula officinalis compared with trolamine for the prevention of acute dermatitis during irradiation for breast cancer.
Pommier P; Gomez F; Sunyach MP; D'Hombres A; Carrie C; Montbarbon X
J Clin Oncol; 2004 Apr; 22(8):1447-53. PubMed ID: 15084618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
